Dose Response of Exercise for Arthritis Management

NCT ID
NCT06880653
Registry status
Recruiting
Study type
Interventional
Phase
Not applicable
Sponsor
University of South Carolina
Conditions
Arthritis, Fibromyalgia (FM), Gout, Lupus Erythematosus, Systemic, Osteoarthritis, Rheumatoid Arthritis (RA)

Overview

ClinicalTrials.gov lists this study as Recruiting.

Official title: Examination of the Dose Response Relationship Between Physical Activity and Arthritis-Attributable Outcomes

Enrollment: 285 participants (Estimated).

What is being studied

  • Behavioral: DREAM Adaptive Intervention

Who may be eligible

Ages
18 Years to no maximum
Sex
All
Healthy volunteers accepted
No

ClinicalTrials.gov lists the following eligibility criteria.

Inclusion Criteria: * 18 years or older * Have a doctor diagnosed form of arthritis, rheumatoid arthritis, gout, lupus, or fibromyalgia * Ability to read and write in English Exclusion Criteria: * Have any contraindications to exercise (besides arthritis) * Engage in \>45 min/week of Actigraph assessed moderate to vigorous intensity activity * Are pregnant, breastfeeding, or planning to become pregnant in the next year * Are planning to relocate out of the Columbia, SC area in the next 12 months, * Do not have a device compatible with Fitbit * Have uncontrolled hypertension (e.g., systolic blood pressure \> 160 mmHg or diastolic blood pressure \> 100 mmHg) * Plan to have a surgery that affects mobility in the next 12 months * Have a serious cognitive impairment. * Not willing to be randomized to any of the 3 conditions, do not believe they could adhere to the goals, or do not believe they could achieve the highest dose of activity (150 minutes/week).

Study locations

1 study location is listed.

Recruiting site status is explicitly provided for 1 location; 1 is listed as Recruiting.

Countries: United States

  • South Carolina, United States: 1

Sample of listed locations

  • University of South Carolina — Columbia, South Carolina, 29208, United States — Recruiting

Study details

Start date
March 28, 2025
Primary completion date
October 1, 2028
Completion date
April 30, 2029
First posted
March 18, 2025
Collaborators
Centers for Disease Control and Prevention

Source and update information

Source
ClinicalTrials.gov
NCT ID
NCT06880653
Registry last updated
April 3, 2026
QualifiedStudies registry data refreshed
October 2, 2026
QualifiedStudies record fetched
October 2, 2026

View NCT06880653 on ClinicalTrials.gov

Trial information can change. Confirm current study details with the study team or the registry.

About joining clinical research

Find clinical trials you may match with

QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.

Find clinical trials you may match with | Clinical trial FAQ